These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4742768)

  • 1. Serum concentrations and biliary excretion of bilirubin during short-term treatment with rifampicin.
    Acocella G; Mattiussi R; Tenconi LT
    Tijdschr Gastroenterol; 1973; 16(3):186-90. PubMed ID: 4742768
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB; Powell-Jackson PR; Davis M; Williams R
    Q J Med; 1981; 50(197):77-82. PubMed ID: 7267969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of the excretion of rifomycin in the bile].
    Nestle W
    Med Welt; 1969 Aug; 32():1741-3. PubMed ID: 5801060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations.
    Acocella G; Segre G
    Acta Pharm Suec; 1974 Dec; 11(6):657-8. PubMed ID: 1136808
    [No Abstract]   [Full Text] [Related]  

  • 6. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
    Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
    Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary excretion of simulateously administered bilirubin and chenodeoxycholic acid in rats with porta-caval shunt.
    Nassuato G; Vassanelli P; Lirussi F; Giacon L; Orlando R; Venuti M; Okolicsanyi L
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):896-9. PubMed ID: 7272064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dehydrocholic, chenodeoxycholic, and taurocholic acids on the excretion of bilirubin.
    Engelking LR; Gronwall R; Anwer MS
    Am J Vet Res; 1980 Mar; 41(3):355-61. PubMed ID: 7369608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion of simultaneously administered bilirubin and chenodeoxycholic acid in rats.
    Nassuato G; Vassanelli P; Lirussi F; Giacon L; Orlando R; Venuti M; Okolicsanyi L
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):891-5. PubMed ID: 7272063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes of bile contents in patients with obstructive jaundice from different etiologies.
    Chen CY; Shiesh SC; Su WC; Chang KK; Lin XZ
    Hepatogastroenterology; 1996; 43(10):796-9. PubMed ID: 8884292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Arch Monaldi; 1970; 25(6):427-40. PubMed ID: 5514802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bile composition and antibiotic excretion. Observations with T-drainage].
    Rosenthal RJ; Steigerwald SD; Bockhorn H
    Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism of rifampicin. I. Biliary and urinary excretion in normal rats and with experimental liver injury].
    Rodriguez Garay EA; Spetale MR; Morisoli LS; Rassero JA
    Farmaco Prat; 1973; 28(9):481-8. PubMed ID: 4751984
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of isoflurane anesthesia on equine liver function.
    Engelking LR; Dodman NH; Hartman G; Valdez H
    Am J Vet Res; 1984 Apr; 45(4):616-9. PubMed ID: 6731976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
    Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
    Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilirubin excretion into bile. I. Effect of the medium on bilirubin secretion. Analysis of criteria for bilirubin excretion].
    Jirsová A; Heringová A; Jirsa M
    Cesk Gastroenterol Vyz; 1972 Jun; 26(4):169-73. PubMed ID: 5047235
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and chronic effects of ethanol on biliary secretion of bilirubin and bile acids.
    Vendemiale G; Lieber CS
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):307-17. PubMed ID: 6545063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.